1. Home
  2. PSTV

as 12-20-2024 3:41pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Founded: 1996 Country:
United States
United States
Employees: N/A City: AUSTIN
Market Cap: 6.3M IPO Year: N/A
Target Price: $13.50 AVG Volume (30 days): 90.1K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.09 EPS Growth: N/A
52 Week Low/High: $0.93 - $2.67 Next Earning Date: 11-14-2024
Revenue: $5,725,000 Revenue Growth: 52.63%
Revenue Growth (this year): 32.12% Revenue Growth (next year): -24.60%

PSTV Daily Stock ML Predictions

Share on Social Networks: